Cantor Fitzgerald upgraded CVS Health (CVS) to Overweight from Neutral.Maximize Your Portfolio with Data Driven Insights:Leverage the power of ...

As previously reported, Cantor Fitzgerald upgraded CVS Health (CVS) to Overweight from Neutral with a price target of $71, up from $62, citing ...

CVS Health beat Wall Street estimates for fourth-quarter profit on Wednesday and provided an annual forecast that largely met ...

CVS Health reported a smaller-than-expected drop in fourth-quarter profit on Wednesday as the pace of medical cost increases slowed at the healthcare conglomerate and revenues jumped in its pharmacy ...

CVS Health has encountered headwinds lately, which could lead to reduced payouts. The underlying business looks somewhat robust but faces significant uncertainty. There are much more attractive ...

We recently published a list of 12 Best Health Insurance Stocks to Buy in 2025. In this article, we are going to take a look at where CVS Health Corporation (NYSE:CVS) stands against other best ...

New features of the app will bring together all CVS Health has to offer to consumers, helping make health care more accessible, affordable and convenient. The CVS Health® Foundation (NYSE ...

Explore the latest updates from Wall Street as U.S. stocks slip due to rising inflation rates affecting consumers' costs.

CVS' diverse operations create the opportunity to view a patient more holistically by managing both medical and pharmacy benefits, which could lead to revenue and cost synergies for the ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

CVS Health's poor 2024 performance was driven by negative macro and micro factors. Investors became too pessimistic about the company's forward prospects. A new CEO is a catalyst. Despite weak ...